Relatlimab Biosimilar - Ultra Low Endotoxin

Relatlimab Biosimilar - Ultra Low Endotoxin, Human IgG4 S228P Kappa
Artikelnummer
ICH5117UL-20mg
Verpackungseinheit
20mg
Hersteller
Ichorbio

Verfügbarkeit: wird geladen...
Preis wird geladen...
Target: LAG3

Specificity: Detects human LAG3

Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Background: Uses the same sequence as the therapeutic antibody Relatlimab

Concentration: 5mg/ml

Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.

Purity: ≥95% monomer by analytical SEC, >95% by SDS Page

Endotoxin: <0.1EU/mg Determined by LAL gel clotting assay

Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Mehr Informationen
Artikelnummer ICH5117UL-20mg
Hersteller Ichorbio
Hersteller Artikelnummer ICH5117UL-20mg
Verpackungseinheit 20mg
Mengeneinheit STK
Reaktivität Human
Klonalität Monoclonal
Methode Functional Assay
Isotyp Human IgG4 S228P Kappa
Produktinformation (PDF) Download
MSDS (PDF) Download